XML Feed for RxPG News   Add RxPG News Headlines to My Yahoo!   Javascript Syndication for RxPG News

Research Health World General
 Asian Health
 Food & Nutrition
 Men's Health
 Mental Health
 Occupational Health
 Public Health
 Sleep Hygiene
 Women's Health
 Canada Healthcare
 China Healthcare
 India Healthcare
 New Zealand
 South Africa
 World Healthcare
   Latest Research
 Alternative Medicine
 Clinical Trials
 Infectious Diseases
  Anorexia Nervosa
  Child Psychiatry
  Forensic Psychiatry
  Mood Disorders
  Peri-Natal Psychiatry
  Personality Disorders
  Sleep Disorders
  Substance Abuse
 Sports Medicine
   Medical News
 Awards & Prizes
   Special Topics
 Odd Medical News

Last Updated: Nov 18, 2006 - 1:55:25 PM

Anorexia Nervosa Channel
subscribe to Anorexia Nervosa newsletter

Latest Research : Psychiatry : Anorexia Nervosa

   DISCUSS   |   EMAIL   |   PRINT
Bulimia-type anorexia nervosa shows increased serotonin binding
Sep 6, 2005 - 6:54:00 AM, Reviewed by: Dr. Ankush Vidyarthi

Women who have had a certain type of anorexia nervosa show an alteration of the activity of a chemical in their brain that is widely associated with anxiety and other affective disorders more than one year after recovery, according to a study in the September issue of Archives of General Psychiatry, one of the JAMA/Archives journals.

Anorexia nervosa, a disorder characterized by the relentless pursuit of thinness and obsessive fear of being fat, has two subtypes, a group that restricts their eating (restricting-type AN) and a group that alternates restrictive eating with bulimic symptoms such as episodes of purging and/or binge eating (bulimia-type AN), according to background information in the article. Previous evidence has suggested that alterations in the activity of serotonin (a brain chemical involved in communication between nerve cells) may contribute to the appetite alteration in anorexia nervosa as well as playing a role in anxious, obsessional behaviors and extremes of impulse control.

Ursula F. Bailer, M.D., of the University of Pittsburgh School of Medicine, Pittsburgh, and colleagues compared the activity of serotonin in women who had recovered from each of the two types of anorexia nervosa and a control group of healthy women using positron emission tomography (PET). The researchers injected a molecule that can bind to a serotonin receptor in much the same way that serotonin does into specific areas of the women's brains and used PET scans to measure the extent of the molecule-receptor binding. This molecule-receptor binding served as a marker for alterations of serotonin neuronal activity. Thirteen women recovered from restricting-type AN, 12 women with bulimia-type AN and 18 healthy control women were included in the study.

The researchers report increased binding of this marker molecule in several brain regions in women who had recovered from bulimia-type AN but not restricting-type AN. Only the women who had recovered restricting-type AN showed any correlation between core eating disorder symptoms and binding potential. In these women receptor binding was correlated with a measure of anxiety called harm avoidance.

"In summary, this study lends further credibility to the possibility that women with AN have a persistent disturbance of 5-HT [serotonin] neuronal systems that may be related to increased anxiety," the authors conclude. "While it cannot be certain whether 5-HT alterations are a 'scar' following cessation of low weight and malnutrition, the fact that premorbid anxiety disorders occur in AN supports the possibility that altered 5-HT pathway function could predate the onset of AN and persist after recovery. There are no proven treatments for AN, and this illness has the highest mortality of any psychiatric disorder. These data offer the promise of a new understanding of the pathogenesis of AN and new drug and psychological treatment targets."


- Arch Gen Psychiatry. 2005; 62: 1032-1041

JAMA and Archives Journals

Subscribe to Anorexia Nervosa Newsletter
E-mail Address:


This study was supported by grants from the National Institute of Mental Health, Bethesda, Md., the Price Foundation, Geneva, Switzerland, and an Erwin-Schrödinger-Fellowship of the Austrian Science Fund.

Related Anorexia Nervosa News
Antidepressants does not decrease risk of relapse in anorexia nervosa
Bulimia-type anorexia nervosa shows increased serotonin binding

For any corrections of factual information, to contact the editors or to send any medical news or health news press releases, use feedback form

Top of Page


© Copyright 2004 onwards by RxPG Medical Solutions Private Limited
Contact Us